Financial and Operational Highlights -- First quarter revenue highlights include:
-- North America. North America revenue declined 7 percent to $235 million. Capital sales declined 6 percent due primarily to a 10 percent decline in patient support systems revenue, partially offset by growth in certain other capital categories. Rental revenue declined 9 percent.
-- International. International segment revenue, excluding Volker, increased 14 percent on a constant currency basis due primarily to growth in Latin America and the Middle East.
International revenue, including Volker, increased 39 percent to $135 million, or 42 percent on a constant currency basis.
-- Surgical/Respiratory Care. Surgical/Respiratory Care revenue increased 84 percent to $59 million, due to the addition of the Aspen Surgical business. Excluding Aspen Surgical, segment revenue decreased 5 percent on lower respiratory care revenues.
-- Operating cash flow for the quarter was $65 million, compared to $62 million in the prior year.
-- Adjusted EBITDA for the quarter was $75 million, compared to $76 million in the prior year.
Please see the attached schedules for additional information, including condensed financial information, summary balance sheet, cash flow statement and reconciliations of GAAP to adjusted financial measures.
For a more complete review of Hill-Rom's results, please refer to our Quarterly Report on Form 10-Q for the quarter ended December 31, 2012.
Financial Guidance Summary Consistent with prior guidance, for full year fiscal 2013, Hill-Rom expects reported revenue growth of 7 to 8 percent. This reflects:
|SOURCE Hill-Rom Holdings, Inc.|
Copyright©2012 PR Newswire.
All rights reserved